Videos Dr. Rahima Jamal is an hematologist-oncologist and the director of the therapeutic innovation unit at the Research Center of the University of Montreal Hospital Center (CRCHUM). Here, she explains the three phases of clinical trials. She discusses the motives for patients who enroll in early-phases clinical trials. Dr. Fred Saad is head of the urology unit of the University of Montréal Hospital Center (CHUM) and researcher at the CHUM Research Center (CRCHUM). Dr. Saad emphasizes the importance of clinical research in treating advanced stages of prostate cancer. His patient, Mr. Yvan Laniel, shares his positive experience with clinical trials. Dr. Diane Provencher is a gynecologist-oncologist at the University of Montreal Hospital Center (CHUM) and a researcher at the CHUM Research Center (CRCHUM). Dr. Provencher communicates the importance of informing patients about clinical trials. Her patient, Sylvie Halde, tells her story and shares her motives for participating in a clinical trial when she was diagnosed with ovarian cancer. We present to you the story of a patient undergoing clinical trials for her metastatic pancreatic cancer. We meet the physician-researcher responsible for treating her, Dr. Gerald Batist, who is also the director of the MCTRC and of the Segal cancer center at the Jewish General Hospital Anne-Marie Mes-Masson, Ph.D., is a researcher at the University of Montréal Hospital Center (CHUM) and scientific director of the cancer research network. She explains how human tissue biobanks work. Pamphlets Clinical trials may raise a lot of questions and apprehensions for cancer patients. This document answers many common questions about clinical trials, guiding your decision. Clinical Research requires a free and informed consent from all participants. This document defines the meaning of these terms in the context of an ethical clinical trial.